|St Jude Medical Inc -- USA Stock|| |
USD 80.82 0.01 0.0124%
Mr. Daniel J. Starks was appointed as Executive Chairman of the Board of St. Jude Medical Inc. effective January 1 2016. He was President Chief Executive Officer of St. Jude Medical Inc. He has served as Chief Operating Officer of St. Jude Medical from January 2001 to May 2004. From April 1998 to February 2001 President and Chief Executive Officer of the Cardiac Rhythm Management Division of St. Jude Medical. Previously Chief Executive Officer and President Daig Corporationrationration
Age: 60 Chairman Since 2016
651 756-3301 www.sjm.com
Daniel Starks Latest Insider Activity
The company has Return on Asset of 0.08 %
which means that on every $100 spent on asset it made $0.08 of profit. This is way below average.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29 which is OK given its current industry classification. St Jude Medical Inc has Current Ratio of 1.89 which is typical for the industry and considered as normal.
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical Inc (STJ) is traded on New York Stock Exchange in USA. It is located in MINNESOTA, U.S.A and employs 18,000 people. St Jude is listed under Medical Equipment category by Fama And French industry classification.